| 000 | 01894 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514023120.0 | ||
| 264 | 0 | _c20020716 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1023/a:1013185125186 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrem, J L | |
| 245 | 0 | 0 |
_aN-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cNov 2001 |
||
| 300 |
_a1581-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aAspartate Carbamoyltransferase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAspartic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aChronotherapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 |
_aGastrointestinal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhosphonoacetic Acid _xadministration & dosage |
| 700 | 1 | _aYee, L K | |
| 700 | 1 | _aSchuler, B | |
| 700 | 1 | _aHamilton, J M | |
| 700 | 1 | _aChen, A P | |
| 700 | 1 | _aChabuk, C | |
| 700 | 1 | _aGrollman, F | |
| 700 | 1 | _aGrabenc, M | |
| 700 | 1 | _aAllegra, C J | |
| 700 | 1 | _aTakimoto, C H | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 12 _gno. 11 _gp. 1581-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1013185125186 _zAvailable from publisher's website |
| 999 |
_c11732480 _d11732480 |
||